ArticlePeerJ. Computer science2025
Fine-tuned deep transfer learning: an effective strategy for the accurate chronic kidney disease classification.
Article in PeerJ. Computer science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Artificial Intelligence in Renal Imaging: A Multi-Dataset Study for Kidney Disease Classification.Biomedicines · 2026Article
- KidneyNeXt: A Lightweight Convolutional Neural Network for Multi-Class Renal Tumor Classification in Computed Tomography Imaging.Journal of clinical medicine · 2025Article
- Early detection of chronic kidney disease using deep learning: a Mini review.Frontiers in digital health · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kidney diseases are becoming an alarming concern around the globe. Premature diagnosis of kidney disease can save precious human lives by taking preventive measures. Deep learning demonstrates a substantial performance in various medical disciplines. Numerous deep learning approaches are suggested in the literature for accurate chronic kidney disease classification by compromising on architectural complexity, classification speed, and resource constraints. In this study, deep transfer learning is exploited by incorporating unexplored yet effective variants of ConvNeXt and EfficientNetV2 for accurate and efficient classification of chronic kidney diseases. The benchmark computed tomography (CT)-based kidney database containing 12,446 CT scans of kidney tumor, stone cysts, and normal patients is utilized to train the designed fine-tuned networks. However, due to the highly imbalanced distribution of images among classes, the operation of data trimming is exploited for balancing the number of CT scans in each class, which is essential for designing an unbiased predictive network. By utilizing fine-tuned pre-trained models for our specific task, the training time is reduced leading to a computationally inexpensive solution. After the comprehensive hyperparameters tuning with respect to changes in learning rates, batch sizes, and optimizers, it is depicted that the designed fine-tuned EfficientNetV2B0 network of 23.8 MB in size with only 6.2 million architectural parameters shows substantial diagnostic performance by achieving a generalized test accuracy of 99.75% on balanced CT kidney database. Furthermore, the designed fine-tuned EfficientNetV2B0 attains high precision, recall, and F1-score of 99.75%, 99.63%, and 99.75%, respectively. Moreover, the final fine-tuned EfficientNetV2B0 ensures its scalability by achieving an impressive diagnostic accuracy of 99.73% on the test set of the original CT kidney dataset as well. Through the extensive evaluation of the proposed transfer learning strategy, it is concluded that the proposed design of fine-tuned EfficientNetV2B0 outperforms its counterparts in terms of accuracy and computational efficiency for chronic kidney disease diagnosis tasks. The final fine-tuned EfficientNetV2B0 serves as an accurate, efficient, and computationally inexpensive solution tailored for real-time deployment on medical or mobile edge devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.